Clonidine Hydrochloride (Tris Pharma)

盐酸可乐定 (Tris Pharma)

Report date: 2026/04/13 20:02:18

Base Information

Drug NameClonidine Hydrochloride (Tris Pharma)
Drug Alias NameClonidine hydrochloride extended release (Tris Pharma)Clonidine extended release (Tris Pharma)ONYDA XROnyda XRNexiclon XR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 agonistsImidazoline receptor agonists
TargetsAdrenergic receptors alpha-2Imidazoline receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2009/12/03
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTris Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesRosemont Pharmaceuticals LtdTris Pharma Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with HyperactivityHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC02AC01N02CX02S01EA04
Related LinksWikipediaDrugBankKEGG